U.S. joins lawsuits against manufacturers over drug Suboxone

Reckitt Benckiser and Invidor, the manufacturers of Suboxone are back in the news. The Justice Department in filings last week in federal court in Abingdon, Virginia, said it was intervening in four separate whistleblower lawsuits related to the Britain-based companies’ marketing of Suboxone and the related drug Subutex. . . . Among the complaints unsealed … Continue reading U.S. joins lawsuits against manufacturers over drug Suboxone

Food for thought on the cyclical nature of drug trends

First, an historical perspective from Bill White: Most drug epidemics don't simply disappear: they transform themselves into something else. For example, periods of excessive stimulant use are often followed by periods of rising alcohol, sedative and opiate use. There are drug facilitated cycles of stimulation, introspection, intoxication, and emotional anesthesia. Repeated episodes of each drug … Continue reading Food for thought on the cyclical nature of drug trends

Study of Long-acting buprenorphine published–17% respond

A new JAMA study concludes, "Long-acting buprenorphine depot formulations appear to be efficacious for treatment of opioid use disorder." Keep reading. They compared the effectiveness of sublingual (oral) and long-acting injections of buprenorphine to see if the long-acting injections are as effective as the sublingual version. The study was 24 weeks. That's better than we … Continue reading Study of Long-acting buprenorphine published–17% respond